Scientific and organizational collaboration in comparative effectiveness research: The VA Cooperative Studies Program model

American Journal of Medicine

Volumn 123, Issue 12 SUPPL., 2010, Pages

  Huang, Grant D ^a   Ferguson, Ryan E ^b   Peduzzi, Peter N ^c,d   O'Leary, Timothy J ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Massachusetts Veterans Epidemiology Research and Information Center   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Clinical research; Clinical trials; Comparative effectiveness; Veterans

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROGRAM; MEDICAL RESEARCH; PRIORITY JOURNAL; ADVISORY COMMITTEE; CLINICAL TRIAL (TOPIC); COOPERATION; GOVERNMENT; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; UNITED STATES;

ADVISORY COMMITTEES; CLINICAL TRIALS AS TOPIC; COMPARATIVE EFFECTIVENESS RESEARCH; COOPERATIVE BEHAVIOR; HUMANS; RESEARCH DESIGN; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 78650458097     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.10.005     Document Type: Article

References (57)

1. P.H. Conway, and C. Clancy Comparative-effectiveness researchimplications of the Federal Coordinating Council's report N Engl J Med 361 2009 328 330
2. H.C. Sox, and S. Greenfield Comparative effectiveness research: a report from the Institute of Medicine Ann Intern Med 151 2009 203 205
3. J.C. Maro, R. Platt, and J.H. Holmes Design of a national distributed health data network Ann Intern Med 151 2009 341 344
4. Institute of Medicine Initial national priorities for comparative effectiveness research 2009 Institute of Medicine Washington, DC
5. Federal Coordinating Council for Comparative Effectiveness Research Report to the President and the Congress 2009 US Department of Health and Human Services Washington, DC
6. S. Durako Inventory and Evaluation of Clinical Research Networks (IECRN) Best Practices Study Report 2006 2006 Westat Rockville, MD
7. S.R. Tunis, D.B. Stryer, and C.M. Clancy Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy JAMA 290 2003 1624 1632
8. J.B. Barnwell Veterans Administration Tuberculosis Division, 1945-1947 Am Rev Tuberc 58 1948 64 76
9. S. Locke, D.C. Kruper, and P.I. Yakovlev Five-year follow-up on multiple sclerosis: report on Veterans Administration Cooperative Study Arch Neurol 11 1964 583 592
10. Veterans Administration Cooperative Study of Atherosclerosis Neurology Section An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease Stroke 11 1961 132 138
11. H.M. Katz, and G. Bissel Blood sugar lowering effects of chlorpropamide and tolbutamide: a double blind cooperative study Diabetes 14 1965 650 657
12. M.L. Murphy, H.N. Hultgren, K.M. Detre, J. Thomsen, and T. Takaro Treatment of chronic stable angina: a preliminary report of survival data of the randomized VA cooperative study N Engl J Med 297 1977 621 627
13. H.D. Lewis, J.W. Davis, and D.G. Archibald Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina N Engl J Med 309 1983 396 403
14. F.C. Jackson, E.B. Perrin, A.G. Smith, A.E. Dagradi, and H.M. Nadal A clinical investigation of the portacaval shunt II. Survival analysis of the prophylactic operation Am J Surg 115 1968 22 42
15. W.J.M. Hrushesky The Department of Veterans Affairs' unique clinical cancer research effort Cancer 74 1994 2701 2709
16. M.W. Linn, E.M. Caffey, C.J. Klett, G.E. Hogarty, and H.R. Lamb Day treatment and psychotropic drugs in the aftercare of schizophrenic patients Arch Gen Psychiatry 36 1979 1055 1066
17. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effects of treatment on morbidity in hypertension: II Results in patients with diastolic blood pressure averaging 90 through 114 mmHg JAMA 213 1970 1143 1152
18. V. Papademetriou Eulogy for Edward D. Freis, MD Am J Cardiol 96 2005 311 312
19. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
20. F.M. Weaver, K. Follett, and M. Stern Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial JAMA 301 2009 63 73
21. P.P. Schnurr, M.J. Friedman, and C.C. Engel Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial JAMA 297 2007 820 830
22. L. Neumayer, A. Giobbie-Hurder, and O. Jonasson Open mesh versus laparoscopic mesh repair of inguinal hernia N Engl J Med 350 2004 1819 1827
23. A.L. Shroyer, F.L. Grover, and B. Hattler On-pump versus off-pump coronary-artery bypass surgery N Engl J Med 361 2009 1827 1837
24. 18F-FDG PET and CT in the characterization of solitary pulmonary nodules J Nucl Med 49 2008 179 185
25. P.M. Palevsky, J.H. Zhang, and T.Z. O'Connor Intensity of renal support in critically ill patients with acute kidney injury N Engl J Med 359 2008 7 20
26. W. Duckworth, C. Abraira, and T. Moritz Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
27. D.A. Fisher, C. Martin, J. Galanko, R.S. Sandler, M.D. Noble, and D. Provenzale Risk factors for advanced disease in colorectal cancer Am J Gastroenterol 99 2004 1 6
28. J.Z. Ayanian, E.A. Chrischilles, and R.B. Wallace Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium J Clin Oncol 22 2004 2992 2996
29. Long-acting Injectable Risperidone in the Treatment of Schizophrenia http://www.clinicaltrials.gov/ct2/show/NCT00132314?term=csp+555&rank=1 Accessed February 11, 2010. Clinicaltrials.gov identifier NCT00132314
30. L.F. Fried, W. Duckworth, and J.H. Zhang Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D) Clin J Am Soc Nephrol 4 2009 361 368
31. Rheumatoid arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy (RACAT) http://www.clinicaltrials. gov/ct2/show/NCT00405275?term=csp+551&rank=1 Accessed February 11, 2010. Clinicaltrials.gov identifier NCT00405275
32. H.P. Selker, and A.J. Wood Industry influence on comparative- effectiveness research funded through health care reform N Engl J Med 361 2009 2595 2597
33. E.O. McFalls, H.B. Ward, and T.E. Moritz Coronary-artery revascularization before elective major vascular surgery N Engl J Med 351 2004 2795 2804
34. J.A. Hagans The design and methodology of cooperative drug trials Drug Intell Clin Pharm 8 1974 531 534
35. K.E. James A model for the development, conduct, and monitoring of multicenter clinical trials in the Veterans Administration Control Clin Trials 1 1908 193 207
36. S.B. Hulley, S.R. Cummings, W.S. Browner, D. Grady, N. Hearst, and T.B. Newman Designing Clinical Research: An Epidemiologic Approach 3rd ed. 2006 Lippincott Williams & Wilkins Philadelphia
37. M.L. Berger, M. Mamdani, D. Atkins, and M.L. Johnson Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources The ISPOR Good Research Practices for Retrospective Database Analysis Task Force ReportPart I Value Health 12 2009 1044 1052
38. M. Roland, and D.J. Torgerson Understanding controlled trials: what are pragmatic trials? BMJ 316 1998 285
39. K.G. Volpp, and A. Das Comparative effectivenessthinking beyond medication A versus medication B N Engl J Med 361 2009 331 333
40. P. Peduzzi, T. Kyriakides, T.Z. O'Connor, P. Guarino, S.R. Warren, and G.D. Huang Methodological issues in comparative effectiveness research: clinical trials Am J Med 123 suppl 2010 e8 e15
41. E.L. Korn, and S. Baumrind Clinician preferences and the estimation of causal treatment differences Stat Sci 13 1998 209 235
42. L. Shaw, and A.M. Chalmers Ethics in cooperative clinical trials Ann N Y Acad Sci 169 1970 487 495
43. B. Freedman Equipoise and the ethics of clinical research N Engl J Med 317 1987 141 145
44. D. Atkins, and J. Kupersmith Implementation research: a critical component of realizing the benefits of comparative effectiveness research Am J Med 123 suppl 2010 e38 e45
45. A.D. Naik, and L.A. Petersen The neglected purpose of comparative-effectiveness research N Engl J Med 360 2009 1929 1931
46. B.R. Luce, J.M. Kramer, and S.N. Goodman Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change Ann Intern Med 151 2009 206 209
47. Clinical Trials Transformation Initiative https://www. trialstransformation.org/ Accessed February 8, 2010
48. S. Yusuf Randomized clinical trials: slow death by a thousand unnecessary policies? CMAJ 171 2004 889 892
49. E.L. Eisenstein, R. Collins, and B.S. Cracknell Sensible approaches for reducing clinical trial costs Clin Trials 5 2008 75 84
50. K. Knight Matrix organization: a review Journal of Management Studies 17 1976 111 130
51. S.M. Davis, and P.R. Lawrence Matrix 1977 Addison-Wesley Publishing Company Reading, MA
52. International Organization for Standardization FAQs on ISO 9001: 2008 http://www.iso.org/iso/iso-catalogue/management-standards/iso-9000-iso-14000/ iso-9001-2008/faqs-on-iso-9001.htm Accessed February 8, 2010
53. A.M. McDonald, R.C. Knight, and M.K. Campbell What influences recruitment to randomized controlled trials? A review of trials funded by two UK funding agencies Trials 7 2006 9
54. L. D'Avolio, W. Farwell, and L. Fiore Medical informatics and comparative effectiveness research Am J Med 123 suppl 2010 e32 e37
55. J.S. March, S.G. Silva, S. Compton, M. Shapiro, R. Califf, and R. Krishnan The case for practical clinical trials in psychiatry Am J Psychiatry 162 2005 836 846
56. M.J. Khoury, E.C. Rich, G. Randhawa, S.M. Teutsch, and J. Niederhuber Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine Genet Med 11 2009 707 711
57. A.M. Garber, and S.R. Tunis Does comparative-effectiveness research threaten personalized medicine? Ann Intern Med 360 2009 1925 1927